The use of triethylenethiophosphoramide as an adjuvant to the surgical treatment of colorectal carcinoma.
D000328:Adult; D001741:Black or African American; D000368:Aged; D003110:Colonic Neoplasms / Q000401:mortality / Q000601:surgery*; D005007:Ethnology; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011183:Postoperative Complications; D012004:Rectal Neoplasms / Q000401:mortality / Q000601:surgery*; D012723:Sex; D013852:Thiotepa / Q000008:administration & dosage / Q000627:therapeutic use*; D044465:White People
D013852:Thiotepa